Zain Syed Hasan - 03 Nov 2026 Form 4 Insider Report for Health In Tech, Inc. (HIT)

Reporting relationship: Chief Growth Officer
Issuer ticker: HIT
Reported as of: 03 Nov 2026
Net transaction value: -$917
SEC form: 4
Accepted by SEC: 05 Nov 2026, 16:30:03 UTC
Prior SEC filing: 19 Oct 2026
Source filing: View source filing
Reporting owner signature: /s/ Lori Babcock, as attorney-in-fact for Zain Hasan

Filing notes and source

Key filing fact

Zain Syed Hasan filed Form 4 for Health In Tech, Inc. (HIT) on 05 Nov 2026.

Key facts

This page summarizes Zain Syed Hasan's Form 4 filing for Health In Tech, Inc. (HIT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 05 Nov 2026, 16:30.

Change

Previous filing in this sequence was filed on 19 Oct 2026.
Current net transaction value: -$917.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002102674 Primary reporting owner

Hasan Zain Syed

Relationship: Chief Growth Officer
Address: 701 S. COLORADO AVE, SUITE 1, STUART
Signature: /s/ Lori Babcock, as attorney-in-fact for Zain Hasan
Signature date: 05 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HIT transaction

Class A Common Stock

Sale

Transaction value: -$917
Shares: -1,667
Change %: -0.96%
Price: $0.5500
Shares after: 171,993
Date: 03 Nov 2026
Ownership: Direct
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2026.

Footnote F2

The reported price in Column 4 is a weighted average price. The reporting person undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price underlying the weighted average price disclosed in this footnote.

Footnote F3

Includes 153,333 restricted shares of Class A Common Stock and 18,660 unrestricted shares of Class A Common Stock.